Xiaofan Zheng1,2,3, Wei Ding2,3, Gan Li2,3, Yaling Wu2,3, Danxiao Wu2,3, Hong Zhu2,3, Ji He2,3, Bin Wang4, Longyou Zhao5, Faming Zhu2,3, Hangjun Lv1,2,3. 1. Wenzhou Medical University, Wenzhou, China. 2. Blood Centre of Zhejiang Province, Hangzhou, China. 3. Key Laboratory of Blood Safety Research, Ministry of Health, Hangzhou, China. 4. Wenzhou Blood Station, Wenzhou, China. 5. Lishui Blood Station, Lishui, Zhejiang, China.
Abstract
BACKGROUND: The high prevalence of hepatitis B and C viruses (HBV and HCV), paralleling the growing epidemic of human immunodeficiency virus (HIV) and Treponema pallidum (TP) infections in the general population, poses a great threat to blood safety in China. This study investigated the prevalence of serological markers for causative agents of transfusion-transmissible infections (TTI), i.e. HBV, HCV, HIV and TP, among volunteer blood donors in five cities/regions of Zhejiang Province, China. MATERIAL AND METHODS: We investigated whole blood and apheresis donations collected at the Blood Services in five cities/regions in Zhejiang Province between January 1, 2006 and December 31, 2012. Two rounds of serological testing were performed for HBsAg, anti-HCV, anti-HIV1/2 and anti-TP using different kits. The rates of serological positivity were calculated and further analysis was performed to examine the association between donors' characteristics and seroprevalence. RESULTS: Of the 1,615,120 donations, approximately 40% came from first-time donors and 60% from repeat donors. The overall seroprevalence rates of HBV, HCV, HIV and TP were 0.51%, 0.25%, 0.15% and 0.52%, respectively. The overall prevalences of HCV and HIV remained relatively steady, whereas the prevalence of TP increased sharply after 2010. However, the prevalence of TTI agents varied among volunteer blood donors in different cities/regions and demographic groups. DISCUSSION: We collected data on the seroprevalence of TTI agents among volunteer blood donors. Although the risk of TTI is low in China compared to that in some developing countries, sensitive screening methods and recruitment of regular donors are still very important for blood safety and availability.
BACKGROUND: The high prevalence of hepatitis B and C viruses (HBV and HCV), paralleling the growing epidemic of human immunodeficiency virus (HIV) and Treponema pallidum (TP) infections in the general population, poses a great threat to blood safety in China. This study investigated the prevalence of serological markers for causative agents of transfusion-transmissible infections (TTI), i.e. HBV, HCV, HIV and TP, among volunteer blood donors in five cities/regions of Zhejiang Province, China. MATERIAL AND METHODS: We investigated whole blood and apheresis donations collected at the Blood Services in five cities/regions in Zhejiang Province between January 1, 2006 and December 31, 2012. Two rounds of serological testing were performed for HBsAg, anti-HCV, anti-HIV1/2 and anti-TP using different kits. The rates of serological positivity were calculated and further analysis was performed to examine the association between donors' characteristics and seroprevalence. RESULTS: Of the 1,615,120 donations, approximately 40% came from first-time donors and 60% from repeat donors. The overall seroprevalence rates of HBV, HCV, HIV and TP were 0.51%, 0.25%, 0.15% and 0.52%, respectively. The overall prevalences of HCV and HIV remained relatively steady, whereas the prevalence of TP increased sharply after 2010. However, the prevalence of TTI agents varied among volunteer blood donors in different cities/regions and demographic groups. DISCUSSION: We collected data on the seroprevalence of TTI agents among volunteer blood donors. Although the risk of TTI is low in China compared to that in some developing countries, sensitive screening methods and recruitment of regular donors are still very important for blood safety and availability.
Authors: Brian Custer; Sean D Sullivan; Thomas K Hazlet; Uchenna Iloeje; David L Veenstra; Kris V Kowdley Journal: J Clin Gastroenterol Date: 2004 Nov-Dec Impact factor: 3.062
Authors: Y Wang; Q M Tao; H Y Zhao; F Tsuda; R Nagayama; K Yamamoto; T Tanaka; H Tokita; H Okamoto; Y Miyakawa Journal: J Hepatol Date: 1994-10 Impact factor: 25.083
Authors: Seyed Mehdi Sajjadi; Ali Akbar Pourfathollah; Saeed Mohammadi; Bijan Nouri; Rostam Hassanzadeh; Fariba Rad Journal: Iran J Public Health Date: 2018-07 Impact factor: 1.429